BG-60366

· BeOne Medicines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BG-60366, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer [Phase 1]

See pricing